121 related articles for article (PubMed ID: 11673109)
1. Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent.
Ding H; Kudo M; Maekawa K; Suetomi Y; Minami Y; Onda H
Hepatol Res; 2001 Nov; 21(3):242-251. PubMed ID: 11673109
[TBL] [Abstract][Full Text] [Related]
2. Value of new contrast harmonic technique for detecting tumor vascularity in hepatocellular carcinoma: Preliminary results.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Jun; 30(2):85-92. PubMed ID: 27278163
[TBL] [Abstract][Full Text] [Related]
3. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors.
Hotta N; Tagaya T; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Clin Imaging; 2005; 29(1):34-41. PubMed ID: 15859016
[TBL] [Abstract][Full Text] [Related]
4. Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: Preliminary results in hepatic tumors.
Wen YL; Kudo M; Maekawa K; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T
J Med Ultrason (2001); 2002 Dec; 29(4):195-204. PubMed ID: 27277964
[TBL] [Abstract][Full Text] [Related]
5. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Sep; 30(3):141-51. PubMed ID: 27278304
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
[TBL] [Abstract][Full Text] [Related]
9. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
Furuse J; Nagase M; Ishii H; Yoshino M
Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contrast-enhanced harmonic ultrasonography and power Doppler ultrasonography for depicting vascularity of hepatocellular carcinoma identified by angiography-assisted CT.
Honda T; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Toyoda H; Ishiguro H; Ogawa S; Takeshima K; Kawachi T; Hibi T; Hayashi K; Katano Y; Fukuda Y; Goto H
Hepatol Res; 2003 Dec; 27(4):315-322. PubMed ID: 14662120
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced agent detection imaging: Early experience in hepatocellular carcinoma.
Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
J Med Ultrason (2001); 2003 Jun; 30(2):77-84. PubMed ID: 27278162
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
13. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
[TBL] [Abstract][Full Text] [Related]
14. Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent levovist.
Migaleddu V; Virgilio G; Turilli D; Conti M; Campisi G; Canu N; Sirigu D; Vincentelli I
AJR Am J Roentgenol; 2004 Jun; 182(6):1505-12. PubMed ID: 15149997
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
[TBL] [Abstract][Full Text] [Related]
16. 1.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Nakano T; Hashimoto A; Shimizu A; Hamataki T
World J Gastroenterol; 2005 Sep; 11(36):5607-13. PubMed ID: 16237752
[TBL] [Abstract][Full Text] [Related]
17. Detection of intratumoral vascularity in small hepatocellular carcinoma by coded phase inversion harmonics.
Wen YL; Zhou P; Kudo M
Intervirology; 2004; 47(3-5):169-78. PubMed ID: 15383726
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
[TBL] [Abstract][Full Text] [Related]
19. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver.
Uggowitzer MM; Kugler C; Mischinger HJ; Gröll R; Ruppert-Kohlmayr A; Preidler KW; Quehenberger F
J Ultrasound Med; 1999 Jul; 18(7):445-51; quiz 453-4. PubMed ID: 10400046
[TBL] [Abstract][Full Text] [Related]
20. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
